ArticleRheumatology (Oxford, England)2023

Comment on: Efficacy and safety of tocilizumab in Behçet's syndrome with refractory arterial lesions: a single-centre observational cohort study in China.

Rıza Can Kardaş et al.PubMed ↗Publisher ↗

No numbers read from the abstract.